UPB

COM:UPSTREAMBIO

Upstream Bio

  • Stock

Last Close

25.15

05/11 20:49

Market Cap

1.35B

Beta: -

Volume Today

475.39K

Avg: -

Upstream Bio Inc is a clinical-stage biotechnology company developing treatments for inflammatory diseases, with an initial focus on severe respiratory disorders. It is developing verekitug, the known antagonist currently in clinical development that targets the receptor for Thymic Stromal Lymphopoietin (TSLP), a cytokine which is a clinically validated driver of inflammatory r...Show More

investor of